Exacerbation of symptoms due to diltiazem in a patient with lambert-eaton myasthenic myopathic syndrome

dc.contributor.authorPathirana, K.D.
dc.contributor.authorHidelaratchi, M.D.P.
dc.date.accessioned2016-01-14T09:41:31Z
dc.date.available2016-01-14T09:41:31Z
dc.date.issued2004
dc.identifier.citationThe Ceylon Medical Journal, 49(04)pp.130-131
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/20994
dc.publisherElsevier. New Delhi
dc.subjectMedical Sciences
dc.subjectCalcium channel blockers
dc.subjectLambert-eaton myasthenic syndrome
dc.subjectDiltiazem
dc.subjectNeuromuscular junction disorders
dc.subjectSide effects
dc.titleExacerbation of symptoms due to diltiazem in a patient with lambert-eaton myasthenic myopathic syndrome
dc.typeArticle

Files